In-Home CARE Act
Summary
The In-Home CARE Act (S3271) was introduced in the Senate on November 20, 2025, and referred to the Health, Education, Labor, and Pensions committee. It is an early-stage bill authorizing competitive grants for family caregiver home visiting programs but specifies no funding amount. There is zero near-term market impact as no legislation has passed, no money has been appropriated, and no companies are directly affected.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S3271 is an early-stage, unfunded authorization bill with zero near-term market impact
- 2.No funding amount is specified; any actual spending requires a separate appropriations bill
- 3.No publicly traded companies are named or directly affected by the bill's grant mechanism
- 4.The bill has not advanced past committee referral in 5 months, indicating negligible passage probability
Market Implications
No market implications exist for this bill. It is a procedural introduction with no funding, no committee action, and no identifiable beneficiaries among publicly traded companies. Retail investors should ignore S3271 as a market signal. The bill's policy area (family caregiver support) touches home health and long-term care sectors, but the legislative mechanism — competitive grants to government agencies and nonprofits — bypasses the public equity markets entirely. No tickers are affected.
Full Analysis
The In-Home CARE Act (S3271) was introduced in the 119th Congress on November 20, 2025, by Senator Cory Booker (D-NJ) with one cosponsor. The bill has been read twice and referred to the Committee on Health, Education, Labor, and Pensions, where it remains. No further legislative action has occurred in the five months since introduction, indicating stalled or very low-priority status. The bill text establishes a grant program through the Administration for Community Living to fund home visiting programs for family caregivers, but it does not specify any authorized or appropriated dollar amount. This is an authorization bill with no funding mechanism, meaning even if passed, actual spending would require a separate appropriations bill. With a single sponsor (junior senator, not committee chair), only one cosponsor, no companion bill, and no action beyond referral, the bill has negligible probability of advancing in this Congress. The healthcare sector is broadly referenced, but no specific contractors, providers, or companies are named in the legislation. No publicly traded company has identifiable revenue exposure from this bill at any stage. The competitive landscape for home care and caregiver support services includes companies like Amedisys (AMED), Addus HomeCare (ADUS), and LHC Group (acquired by UnitedHealth Group/Optum in 2023, now private under UNH as a subsidiary), but none are named or directly referenced in the bill text. The grant mechanism targets eligible organizations defined as local government agencies, healthcare entities, or nonprofits — not publicly traded corporations. The timeline for any potential market impact requires the bill to first pass the Senate committee, then the full Senate, then the House, then be signed into law, followed by a separate appropriations process that has not been initiated. Given no action since November 2025, this is effectively a dead letter for the current Congress with no market relevance.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Fair Wages for Home Care Workers Act
A bill to amend title XVIII of the Social Security Act to establish a Medicare home care benefit, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →